Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

2.8. Cervical Samples

LO Leslie Olmedo-Nieva
JM J. Omar Muñoz-Bello
IM Imelda Martínez-Ramírez
AM Antonio Daniel Martínez-Gutiérrez
YO Yunuen Ortiz-Pedraza
CG Claudia González-Espinosa
VM Vicente Madrid-Marina
KT Kirvis Torres-Poveda
MB Margarita Bahena-Roman
ML Marcela Lizano
request Request a Protocol
ask Ask a question
Favorite

A cohort of samples from Mexican patients with normal and premalignant lesions of the uterine cervix was tested for RIPOR2 expression, formed by 17 normal HPV-negative cervical samples, 7 normal HPV-positive cervical samples, 20 low-grade, and 15 high-grade cervical premalignant lesions, kindly provided by the Instituto Nacional de Salud Pública (INSP). In addition, 19 cervical cancer samples from the Tumor BioBank from the Instituto Nacional de Cancerología of Mexico City (INCan) were included. The protocol was revised and accepted on February 2017, by the Scientific and Ethical committees of INCan Ref. (017/007/IBI)(CEI/1144/17). All patients whose samples were utilized in this study agreed and signed the informed consent.

Copyright and License information:  ©2022 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A